000 06491cam a2200973 i 4500
001 on1096298025
003 OCoLC
005 20220712085934.0
006 m o d
007 cr cn|||||||||
008 190602s2019 dcuab obt 000 0 eng
040 _aNLM
_beng
_erda
_epn
_cNLM
_dEBLCP
_dCUS
_dOCLCF
_dN$T
_dXFF
_dNLM
_dOCLCQ
_dOCLCO
_dOCLCQ
_dOCLCA
_dUKAHL
_dOCLCQ
_dOCLCO
_dOCLCA
_dK6U
_dOCLCO
016 7 _a101748697
_2DNLM
020 _a9780309486514
_q(electronic bk.)
020 _a0309486513
_q(electronic bk.)
020 _z9780309486484
020 _z0309486483
029 0 _aNLM
_b101748697
029 1 _aAU@
_b000065375988
035 _a(OCoLC)1096298025
042 _apcc
043 _an-us---
050 4 _aRC568.O45
060 0 0 _a2019 F-954
060 1 0 _aWM 284
082 0 4 _a615.7/822
_223
049 _aMAIN
245 0 0 _aMedications for opioid use disorder save lives /
_cCommittee on Medication-Assisted Treatment for Opioid Use Disorder ; Alan I. Leshner and Michelle Mancher, editors ; Board on Health Sciences Policy, Health and Medicine Division.
264 1 _aWashington, DC :
_bNational Academies Press,
_c[2019]
300 _a1 online resource (1 PDF file (xviii, 156 pages)) :
_billustrations, maps
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_2rda
347 _bPDF
490 1 _aConsensus study report of the National Academies of Sciences, Engineering, Medicine
504 _aIncludes bibliographical references.
520 3 _aThe opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
536 _aThis activity was supported by a contract between the National Academy of Sciences and the National Institutes of Health (HHSN263201800029I/HHSN26300005) and the Substance Abuse and Mental Health Services Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
588 0 _aOnline resource; title from PDF title page (viewed August 23, 2019).
505 0 _aIntroduction -- The effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder -- Appendixes
590 _aeBooks on EBSCOhost
_bEBSCO eBook Subscription Academic Collection - Worldwide
650 0 _aOpioid abuse
_xTreatment
_zUnited States.
_91229041
650 0 _aDrug addicts
_xRehabilitation
_zUnited States.
_9937756
650 0 _aOpioids
_xOverdose
_xTreatment
_zUnited States.
_91229042
650 0 _aBrain
_xDiseases
_xTreatment
_zUnited States.
_91229043
650 0 _aOpioid abuse
_xPrevention
_xGovernment policy.
_91229044
650 0 _aMethadone maintenance
_zUnited States.
_91229045
650 0 _aBuprenorphine
_xTherapeutic use
_zUnited States.
_91229046
650 0 _aNaloxone
_xTherapeutic use
_zUnited States.
_91229047
650 0 _aNaltrexone
_xTherapeutic use
_zUnited States.
_91229048
650 0 _aDrugs
_xOverdose.
_9884926
650 1 2 _aOpiate Substitution Treatment
_91170329
650 1 2 _aOpioid-Related Disorders
_xdrug therapy
_91170327
650 2 2 _aDrug Users
_91229049
650 2 2 _aDrug Overdose
_9884928
651 2 _aUnited States
650 6 _aToxicomanie aux opiacés
_xTraitement
_zÉtats-Unis.
_91229050
650 6 _aToxicomanes
_xRéadaptation
_zÉtats-Unis.
_9937761
650 6 _aOpioïdes
_xSurdosage
_xTraitement
_zÉtats-Unis.
_91229051
650 6 _aCerveau
_xMaladies
_xTraitement
_zÉtats-Unis.
_91229052
650 6 _aMéthadone
_xEmploi en thérapeutique
_zÉtats-Unis.
_91229053
650 6 _aBuprénorphine
_xEmploi en thérapeutique
_zÉtats-Unis.
_91229054
650 6 _aNaloxone
_xEmploi en thérapeutique
_zÉtats-Unis.
_91229055
650 6 _aNaltrexone
_xEmploi en thérapeutique
_zÉtats-Unis.
_91229056
650 6 _aMédicaments
_xSurdosage.
_9884933
650 7 _aBrain
_xDiseases
_xTreatment.
_2fast
_0(OCoLC)fst00837618
_91000373
650 7 _aBuprenorphine
_xTherapeutic use.
_2fast
_0(OCoLC)fst00841660
650 7 _aDrug addicts
_xRehabilitation.
_2fast
_0(OCoLC)fst01430276
_9102518
650 7 _aMethadone maintenance.
_2fast
_0(OCoLC)fst01018549
_9127951
650 7 _aOpioid abuse
_xTreatment.
_2fast
_0(OCoLC)fst01430931
_9280185
651 7 _aUnited States.
_2fast
_0(OCoLC)fst01204155
655 0 _aElectronic books.
655 4 _aElectronic books.
700 1 _aMancher, Michelle,
_eeditor.
_9710099
700 1 _aLeshner, Alan I.,
_d1944-
_eeditor.
_91229057
710 2 _aNational Academies of Sciences, Engineering, and Medicine (U.S.).
_bCommittee on Medication-Assisted Treatment for Opioid Use Disorder,
_eissuing body.
_91229058
830 0 _aConsensus study report.
_91172319
856 4 0 _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2186517
938 _aAskews and Holts Library Services
_bASKH
_nAH36618616
938 _aProQuest Ebook Central
_bEBLB
_nEBL5774508
938 _aEBSCOhost
_bEBSC
_n2186517
994 _a92
_bINOPJ
999 _c2838041
_d2838041